Mallinckrodt looking to delay $200 million opioid payment

(Reuters) – Mallinckrodt is searching for to postpone a $200 million opioid settlement cost, Bloomberg Information reported on Thursday citing individuals with data of the matter.

The drugmaker needs lenders to waive off provisions that may make Mallinckrodt a defaulter if it skipped the opioid cost due June 16, the report stated.

Mallinckrodt didn’t instantly reply to a Reuters request for remark.

The corporate earlier this month stated it was contemplating a second chapter submitting and different choices after its lenders raised issues over the $200 million cost.

Mallinckrodt emerged from chapter final 12 months after successful courtroom approval for a reorganization plan that included a $1.7 billion settlement of the litigation.

(Reporting by Raghav Mahobe in Bengaluru; Enhancing by Krishna Chandra Eluri)

Check Also

Food pantries to receive additional $250K from Family Dollar Settlement, Ohio AG says

Ohio meals banks will likely be benefiting from the state‚Äôs settlement with Household Greenback. >>PREVIOUS …

Leave a Reply

Your email address will not be published. Required fields are marked *